Our Bureau, Bengaluru Wednesday, March 19, 2025, 13:15 Hrs [IST] ...

Oncorena, a Swedish pharma company, announced that the US FDA has approved the company’s IND application to initiate the phase I/II study Oncorella-1: A phase 1/2, open label, single arm study on ...

Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset: Our Bureau, Bengaluru Wednesday, March ...

USV launches empagliflozin and its combinations for diabetes care in India: Our Bureau, Bengaluru Wednesday, March 19, 2025, 12:40 Hrs [IST] USV, an Indian multinational healthcar ...

Our Bureau, Bengaluru Wednesday, March 19, 2025, 12:30 Hrs [IST] ...

HaystackAnalytics unveils ‘TB One’ solution to strengthen India's TB control efforts: Our Bureau, Bengaluru Wednesday, March ...

Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...

Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882: San Diego Wednesday, March 19, 2025, 11:00 Hrs [IST] Arthrosi Therape ...

Enlivex to receive Chinese patent for use of Allocetra as a potential treatment in patients with osteoarthritis: Nes-Ziona, Israel Wednesday, March 19, 2025, 10:00 Hrs [IST] Enliv ...

Glasgow, Scotland Wednesday, March 19, 2025, 09:00 Hrs [IST] ...

Exporters raise alarm over new Export NOC guidelines, seek urgent resolution: Shardul Nautiyal, Mumbai Wednesday, March 19, 2025, 08:00 Hrs [IST] Pharmaceutical exporters have rai ...

Nandita Vijayasimha, Bengaluru Wednesday, March 19, 2025, 08:00 Hrs [IST] ...